Elsevier secures publishing rights for premium titles for 2023
Amsterdam | November 14, 2022
Titles from six prominent medical societies to be added to publisher’s direct subscription portfolio
Elsevier, a leading scientific publisher, and global information analytics business specializing in science and health, announced today that it will be the new publisher of six influential society journals starting in January 2023:
American Journal of Clinical Nutrition
The Journal of Nutrition
Journal of Thrombosis and Haemostasis
American Journal of Transplantation
Laboratory Investigation
Modern Pathology
The newly acquired titles represent the following societies and add to Elsevier’s expansive global health publishing portfolio:
American Society for Nutrition (ASN)
United States and Canadian Academy of Pathology (USCAP)
International Society on Thrombosis and Haemostasis (ISTH)
The American Society of Transplant Surgeons (ASTS)
American Society of Transplantation (AST)
All are considered internationally renowned sources of knowledge and impactful study in the fields of pathology, nutrition, transplantation, haematology and peripheral vascular disease.
“It is an honor to partner with five established societies that have trusted Elsevier as the official publisher of their important journals. True to our commitment to supporting research and clinical practice, we are dedicated to placing our full range of industry-leading resources for authors, editors, reviewers and readers, in the disposal of our latest additions. With our continuous support and seamless collaboration these six valued titles can harness the benefits of a reliable global publishing partner allowing them to maximize their contribution to scientific research and clinical practice in their respective fields” said Carl Schwarz Senior Vice President, Health and Medical Sciences, at Elsevier. Elsevier will officially welcome the journals into their portfolio beginning in January 2023. They will be part of Elsevier’s title-by-title subscription model instead of a collection.
Learn more about these exceptional titles or contact us for more information.
About Elsevier
Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies to help impact makers achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.
Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @ElsevierConnect.
Contact

DD